Alphamab Oncology
Overview
Alphamab Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative biologics for cancer treatment. The company leverages its proprietary bispecific and multivalent technology platforms to develop a pipeline of oncology therapies addressing unmet medical needs.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Alphamab Oncology in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.